［1］Fukazawa R, Ogawa S. Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis［J］. J Nippon Med Sch, 2009, 76(3):124-133.
［2］KD Codispoti C, Boyd S, Sees D, Conner W. Symptomatic coronary obstruction due to Kawasaki disease in an adult［J］. Ann Thorac Surg, 2008, 85(3): 1081-1083.
［3］Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, et al. Case-control study of giant coronary aneurysms due to Kawasaki disease［J］. Pediatr Int, 2003, 45(4): 410-413.
［4］陈嫕，王荣发，刘芳．对大剂量静脉丙种球蛋白初治无效的川崎病的处治及相关因素探讨［J］．中国当代儿科杂志，2004，6（1）：59-61．
［5］胡亚美，江载芳．诸福棠实用儿科学［M］．第7版．北京：人民卫生出版社，2002：698-705．
［6］杜忠东，梁璐，孟晓萍，李棠，张拓红，川崎富作，等．1995～1999年北京住院小儿川崎病流行病学调查［J］．中华医学杂志，2003，83(21)：1874-1878．
［7］张永兰，杜忠东，赵地，杜军保，鲁珊，衣京梅，等．2000~2004年北京川崎病住院患儿流行病学调查［J］．实用儿科临床杂志，2007，22(1)：12-15．
［8］Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease［J］. N Engl J Med, 2007, 356(7):663-675.
［9］Burns JC. The riddle of Kawasaki disease［J］. N Engl J Med, 2007, 356(7):659-661.
［10］Tsuda E, Kamiya T, Ono Y, Kimura K, Echigo S. Dilated coronary arterial lesions in the late period after Kawasaki disease［J］. Heart, 2005, 91(2):177-182.
［11］Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients［J］. Circulation, 1996, 94(6):1379-1385.
［12］Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, et al. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease［J］. Pediatr Int, 2004, 46(1):33-38.
［13］Kim T, Choi W, Woo CW, Choi B, Lee J, Lee K, et al. Predictive risk factors for coronary artery abnormalities in Kawasaki disease［J］. Eur J Pediatr, 2007, 166(5):421-425.
［14］张建军，张爱真，韩秀珍．川崎病冠状动脉损害超声心动图及心电图分析［J］．实用儿科临床杂志，2005，20(3)：237-238．